Does #pharma do risk communication well?
Effective risk management is a central element of successful drug safety that remains a discussion point of the industry. With the vast amount of effort that goes into devising and implementing a risk management plan, the communication element of this plays a make or break role in the safest use of medicine. Getting the right message across to the right stakeholder, be that physician, pharmacist or the patient in a clear and understandable way is vital.
At last years World Drug Safety Congress Europe we had a wonderful and energetic round table session led by Philippe Van der Auwera (Roche), Ute Hoeffner (Novartis), Ameet Bakhai, and David Haerry. This gave us a great mixture of perspectives from the industry, physician and patient. The session focussed on how we can effectively communicate risk and had input from the 4 contributing speakers as well as extensive input from the industry delegation. The room was asked to come up with existing and innovative solutions to improving insights into communication and look at how we can improve the capture of adverse drug effects. We then voted on the ones we believed would be most effective in the industry today.
I think this is some really interesting reading. The two solutions out in front are for patients to be more involved in prescribing decisions and to help patient understanding at a young age by educating children about medications and adverse events. Other suggestions that were popular solutions were for the industry to maintain the human touch rather than rely on Google and to have a triage consultation with patients.
What do you think? Would these solutions work in the environment today or would it be too hard to implement? Are there any other solutions that we missed out?